story of the week
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
N. Engl. J. Med 2023 Jun 04;[EPub Ahead of Print], IK Mellinghoff, MJ van den Bent, DT Blumenthal, M Touat, KB Peters, J Clarke, J Mendez, S Yust-Katz, L Welsh, WP Mason, F Ducray, Y Umemura, B Nabors, M Holdhoff, AF Hottinger, Y Arakawa, JM Sepulveda, W Wick, R Soffietti, JR Perry, P Giglio, M de la Fuente, EA Maher, S Schoenfeld, D Zhao, SS Pandya, L Steelman, I Hassan, PY Wen, TF CloughesyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.